Código QR (código de barras bidimensional)

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial

Abstract Background The role of adjuvant radiation in pancreatic adenocarcinoma (PDAC) remains unclear. We aimed to investigate the efficacy of gemcitabine combined with stereotactic body radiation therapy (SBRT) as adjuvant therapy for resected stage II PDAC. Methods In this single-center randomize...

ver descrição completa

Na minha lista:
Principais autores: Tao Ma, Xueli Bai, Qichun Wei, Yongjie Shui, Mengyi Lao, Wen Chen, Bingfeng Huang, Risheng Que, Shunliang Gao, Yun Zhang, Wei Chen, Ji Wang, Tingbo Liang
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-08-01
coleção:BMC Cancer
Assuntos:
Pancreatic adenocarcinoma
Adjuvant therapy
Gemcitabine
SBRT
Randomized controlled trial
Acesso em linha:https://doi.org/10.1186/s12885-022-09974-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados